AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+3.42%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$9.74B
AUM Growth
+$4.74B
(+95%)
Cap. Flow
+$4.51B
Cap. Flow
% of AUM
46.35%
Top 10 Holdings %
Top 10 Hldgs %
64.11%
Holding
550
New
164
Increased
124
Reduced
128
Closed
110
Top Buys
| 1 |
Microsoft
MSFT
|
$1.04B |
| 2 |
Apple
AAPL
|
$738M |
| 3 |
TSMC
TSM
|
$611M |
| 4 |
Global X Cybersecurity ETF
BUG
|
$521M |
| 5 |
Amazon
AMZN
|
$510M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$522M |
| 2 |
Synchrony
SYF
|
$162M |
| 3 |
Simon Property Group
SPG
|
$28.7M |
| 4 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
$21.2M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
$18.1M |
Sector Composition
| 1 | Technology | 42.39% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Communication Services | 12.44% |
| 4 | Consumer Staples | 6.28% |
| 5 | Financials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUNA
276
DELISTED
Luna Innovations Incorporated
LUNA
| $58K | ﹤0.01% |
+5,487
| New | +$58K |
|
277
PayPal
PYPL
$65.2B
| $57K | ﹤0.01% |
235
-14
| -6% | -$3.4K |
|
|
BCOV
278
DELISTED
Brightcove, Inc.
BCOV
| $57K | ﹤0.01% |
+2,833
| New | +$57K |
|
279
Agilysys
AGYS
$3.1B
| $56K | ﹤0.01% |
+1,171
| New | +$56K |
|
280
TechTarget
TTGT
$403M
| $56K | ﹤0.01% |
804
-219
| -21% | -$15.3K |
|
281
Appian
APPN
$2.26B
| $53K | ﹤0.01% |
+401
| New | +$53K |
|
282
Smith Micro Software
SMSI
$15.5M
| $50K | ﹤0.01% |
+1,129
| New | +$50K |
|
283
Agilent Technologies
A
$36.5B
| $49K | ﹤0.01% |
388
-4,380
| -92% | -$553K |
|
284
Organogenesis Holdings
ORGO
$634M
| $48K | ﹤0.01% |
+2,613
| New | +$48K |
|
|
SWAV
285
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $47K | ﹤0.01% |
362
-25
| -6% | -$3.25K |
|
286
Abbott
ABT
$231B
| $46K | ﹤0.01% |
385
+46
| +14% | +$5.5K |
|
287
Cooper Companies
COO
$13.5B
| $46K | ﹤0.01% |
+484
| New | +$46K |
|
|
ICAD
288
DELISTED
iCAD Inc
ICAD
| $45K | ﹤0.01% |
+2,134
| New | +$45K |
|
289
Guardant Health
GH
$7.5B
| $44K | ﹤0.01% |
+286
| New | +$44K |
|
290
InfuSystem Holdings
INFU
$208M
| $44K | ﹤0.01% |
+2,183
| New | +$44K |
|
291
Veracyte
VCYT
$2.55B
| $44K | ﹤0.01% |
813
+225
| +38% | +$12.2K |
|
|
AMED
292
DELISTED
Amedisys
AMED
| $43K | ﹤0.01% |
161
+19
| +13% | +$5.08K |
|
293
AngioDynamics
ANGO
$436M
| $43K | ﹤0.01% |
+1,847
| New | +$43K |
|
294
Fulgent Genetics
FLGT
$672M
| $43K | ﹤0.01% |
+446
| New | +$43K |
|
295
Inogen
INGN
$219M
| $43K | ﹤0.01% |
+823
| New | +$43K |
|
296
Logitech
LOGI
$15.8B
| $43K | ﹤0.01% |
406
-69
| -15% | -$7.31K |
|
297
Bruker
BRKR
$4.68B
| $42K | ﹤0.01% |
650
-22
| -3% | -$1.42K |
|
298
Eli Lilly
LLY
$652B
| $42K | ﹤0.01% |
+31,498
| New | +$42K |
|
299
Progyny
PGNY
$1.94B
| $42K | ﹤0.01% |
+937
| New | +$42K |
|
300
SI-BONE Inc
SIBN
$703M
| $42K | ﹤0.01% |
+1,307
| New | +$42K |
|